Clinical Trial Update: A Study to Assess the Safety and Effectiveness of SJP-0035 for the Treatment of Patients With Dry Eye Disease [Phase 3]

View source ↗

Summary

Phase 3 trial update for SJP-0035 in dry eye disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• SJP-0035 (unknown)

Snippet

Sponsor: Senju Pharmaceutical Co., Ltd. | Conditions: Dry Eye Syndromes | Phase 3 | Status: COMPLETED